These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2686073)

  • 21. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J; Ramdani A; Vitré MT; Mignon M
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human tolerability and pharmacodynamic study of Tisacid tablet in duodenal ulcer patients. A prospective, randomized, self-controlled clinicopharmacological study.
    Nagy L; Tárnok F; Past T; Mózsik G; Deák G; Tapsonyi Z; Fendler K; Jávor T
    Acta Med Hung; 1988; 45(2):231-47. PubMed ID: 3073355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evidence of the cytoprotective action of antacids. Behavior of the transmural stomach electric potential difference with antacids in healthy subjects and stomach ulcer patients].
    Tympner F
    Fortschr Med; 1985 Sep; 103(33):795-8. PubMed ID: 4054802
    [No Abstract]   [Full Text] [Related]  

  • 24. Antacids and anticholinergics in the treatment of duodenal ulcer.
    Walan A
    Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevention of stress ulcers in intensive care. Cimetidine and alkalines as prophylaxis of digestive hemorrhage].
    Pepcak F; Forster A; Maurer J; Suter P
    Cah Anesthesiol; 1984; 32(1):11-4. PubMed ID: 6529628
    [No Abstract]   [Full Text] [Related]  

  • 26. [Value of Maalox in the treatment of eso-gastro-duodenal inflammatory and ulcerative diseases].
    Pillegand B; Rumeau JM; Hessel L; Croguennec B
    Med Chir Dig; 1977; 6(8):575-7. PubMed ID: 611345
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of duodenal ulcers with antacids].
    Ottenjann R; Kunert H; Weingart J; Höchter W
    Z Gastroenterol; 1983 Mar; 21 Suppl():74-80. PubMed ID: 6858412
    [No Abstract]   [Full Text] [Related]  

  • 28. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
    Mahachai V; Walker K; Pinchbeck B; Thomson AB
    Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current principles of antacid therapy].
    Grebenev AL; Sheptulin AA
    Klin Med (Mosk); 1993; 71(3):12-5. PubMed ID: 8015207
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of Nilacid treatment in ulcer.
    Figus AI; Papp I; Bajza Y
    Ther Hung; 1986; 34(1):54-6. PubMed ID: 2833824
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo and in vitro evaluation of liquid antacids.
    Fordtran JS; Morawski SG; Richardson CT
    N Engl J Med; 1973 May; 288(18):923-8. PubMed ID: 4693244
    [No Abstract]   [Full Text] [Related]  

  • 32. [The use of 3rd-generation antacid preparations for the treatment of patients with nonulcerous dyspepsia and peptic ulcer complicated by reflux esophagitis].
    Degtiareva II; Bogdanov A; Khatib Z; Kharchenko NV; Lodianaia EV; Palladina OL; Opanasiuk ND
    Lik Sprava; 1994; (5-6):119-22. PubMed ID: 7831874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent ulcer after successful treatment with cimetidine or antacid.
    Ippoliti A; Elashoff J; Valenzuela J; Cano R; Frankl H; Samloff M; Koretz R
    Gastroenterology; 1983 Oct; 85(4):875-80. PubMed ID: 6350097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro assessment of antacid efficacy using a computer-controlled 'artificial stomach-duodenum' model reproducing gastroduodenal flux regulation.
    Vatier J; Cai S; Célice-Pingaud C; Castela-Papin N; Mignon M; Farinotti R
    Therapie; 1996; 51(2):147-54. PubMed ID: 8763049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis, prevention and treatment of postoperative reflux gastritis].
    Pomelov VS; Baramidze GG
    Khirurgiia (Mosk); 1994 May; (5):32-5. PubMed ID: 8057619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical, endoscopic and histological evaluation in the treatment of duodenal ulcer; effect of an alkaline agent, antipeptic drug and a placebo].
    Silva JJ; Leão GC; Zaterka S; Bettarello A
    Rev Hosp Clin Fac Med Sao Paulo; 1978 Jun; 33(3):158-62. PubMed ID: 356158
    [No Abstract]   [Full Text] [Related]  

  • 37. [Circadian changes in gastric acidity during drug therapy of duodenal ulcer].
    Matincheva R; Mateva L; Ivanov S
    Vutr Boles; 1983; 22(6):52-8. PubMed ID: 6689509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of a new antacid, synthetic hydrotalcite, in duodenal ulcer: clinical endoscopic study compared to cimetidine].
    Piai G; Cimino L; D'Argenio G; Mazzacca G
    Clin Ter; 1980 Nov; 95(3):269-77. PubMed ID: 7214842
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antisecretory effects of quamatel and gastrocepin in duodenal ulcer: comparison with intragastric pH-metry].
    Sheptulin AA; Okhlobystin AV
    Klin Med (Mosk); 1998; 76(8):38-40. PubMed ID: 9770967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of omeprazole, a substituted benzimidazole, on 24-h intragastric acidity in patients with peptic ulcer disease.
    Naesdal J; Bodemar G; Walan A
    Scand J Gastroenterol; 1984 Oct; 19(7):916-22. PubMed ID: 6531660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.